| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/NDT/GFL044 |
| P698 | PubMed publication ID | 16490741 |
| P2093 | author name string | Coen van Guldener | |
| P2860 | cites work | Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation | Q36273309 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1161-1166 | |
| P577 | publication date | 2006-02-20 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? | |
| P478 | volume | 21 |
| Q88801159 | Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients |
| Q33431908 | Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab |
| Q46124630 | Chronic Kidney Disease Induces Inflammatory CD40+ Monocyte Differentiation via Homocysteine Elevation and DNA Hypomethylation |
| Q38401394 | Coagulation profile in patients with chronic kidney disease before and after kidney transplantation: A retrospective cohort study. |
| Q35062523 | Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease |
| Q36988161 | Correlation of serum homocysteine and previous history of gestational diabetes mellitus |
| Q34501679 | Cystathionine β-synthase and cystathionine γ-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation |
| Q36171329 | DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney |
| Q44899967 | Effect of nephrotic syndrome on homocysteine metabolism |
| Q53333126 | Elevated plasma homocysteine level is not primarily related to Alzheimer's disease. |
| Q35968147 | Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. |
| Q38227415 | Endothelial dysfunction: the link between homocysteine and hydrogen sulfide |
| Q43424643 | Erythrocyte glutathione transferase activity: a possible early biomarker for blood toxicity in uremic diabetic patients. |
| Q48065983 | Folate and vitamin B-6 status are not associated with homocysteine, oxidative stress and antioxidant capacities in patients with hepatocellular carcinoma |
| Q100635016 | Gender- and age-related differences in homocysteine concentration: a cross-sectional study of the general population of China |
| Q56672658 | Glyphosate’s Suppression of Cytochrome P450 Enzymes and Amino Acid Biosynthesis by the Gut Microbiome: Pathways to Modern Diseases |
| Q33953983 | Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role? |
| Q31140389 | Homocysteine and Real-Space Navigation Performance among Non-Demented Older Adults |
| Q36971878 | Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease |
| Q38948319 | Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension |
| Q38872895 | Homocysteine as a predictive biomarker in early diagnosis of renal failure susceptibility and prognostic diagnosis for end stages renal disease. |
| Q38223130 | Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator |
| Q33583592 | Homocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementia |
| Q89861373 | Homocysteine: Its Possible Emerging Role in At-Risk Population Groups |
| Q39041123 | Hypermethylation: Causes and Consequences in Skeletal Muscle Myopathy. |
| Q24240554 | Interventions for lowering plasma homocysteine levels in dialysis patients |
| Q26471859 | Interventions for lowering plasma homocysteine levels in dialysis patients |
| Q64948754 | Lack of Relationships Between Serum Prolactin Concentrations and Classical Cardiovascular Risk Factors in Eastern Croatian Older Adults. |
| Q36087847 | Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial |
| Q35016579 | Mechanisms of hyperhomocysteinemia induced skeletal muscle myopathy after ischemia in the CBS-/+ mouse model |
| Q90230531 | New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease |
| Q46001028 | Pharmacological dose of vitamin B12 is as effective as low-dose folinic acid in correcting hyperhomocysteinemia of hemodialysis patients. |
| Q57696914 | Redox-based selective fluorometric detection of homocysteine |
| Q91968784 | Serum concentration of homocysteine in spontaneous feline chronic kidney disease |
| Q100559863 | Serum metabolomics approach to monitor the changes in metabolite profiles following renal transplantation |
| Q58669902 | Signaling pathway genes for blood pressure, folate and cholesterol levels among hypertensives: an epistasis analysis |
| Q38794990 | The relationship between hyperhomocysteinemia and neurodegeneration. |
| Q36285918 | Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine |
| Q41858575 | Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements |
| Q38053468 | Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events |
Search more.